The Effectiveness of Misoprostol Single Dose Oral for Evacuation of Incomplete Abortion
DOI:
https://doi.org/10.30595/pharmacy.v16i2.4591Keywords:
effectiveness, incomplete abortion, misoprostolAbstract
This study is aimed to find out the effectiveness of oral 600 mcg single dose misoprostol for the evacuation of conception remnant in cases of incomplete abortion. This research is done by quasi experimental method with one group pretest – posttest design. The population of the study is all women who were diagnosed with incomplete abortion in less than 12 weeks of gestation in Cipto Mangunkusumo National general Hospital and affiliations hospital from June 2018 to June 2019. Women who met the study criteria, was treated with oral misoprostol 600 mcg single dose and then undergo conception evacuation evaluation and side effects evaluation. Effectiveness evaluation was seen after 7 days of single dose 600 mcg of misoprostol by measuring <15 mm endometrial thickness on transvaginal ultrasound. The effectiveness of using single dose oral misoprostol 600 mcg in the study participants was 93.55%, which were 29 out of a total of 31 participants. The side effects experienced after being given misoprostol were bleeding with less than the same amount as menstruation (71.0% and 9.0%), diarrhea (6.5%), and shivering (67.7%), and not found side effects of vomiting. Based on data analysis using paired T test before and 24 hours after administration of misoprostol, there was a significant difference between endometrial thickness (p value <0.001). Misoprostol 600 mcg per oral dose is effective for the evacuation of retained conception tissue of incomplete abortion at less than 12 weeks gestation, so that it can be an alternative non-operative method of evacuating retained conception tissue in incomplete abortion cases other than the operative method. Side effects found were bleeding, diarrhea, and chills. Side effects of vomiting were not found in this study.
References
Cunningham, G.F., Leveno, K.J., Bloom, S.L., Spong, C.Y., Dashe, J.S., Hoffman, B.L. 2014. Williams Obstetrics. 24th edition. New York: McGraw-Hill Education.
Seifert, S., Altman, K. 2015. Miscarriage and recurrent pregnancy loss in The John Hopkins Manual of Gynecology and Obstetrics. Eds Johnson, C.T., Hallock, J.L., Bienstock, J.L., Fox, H.E., Wallach, E.E. 5th edition. Philadelphia: Lippincott Williams & Wilkins.
FIGO. Dosage guidelines. Misoprostol.org. 2017. Available from: http://www.misoprostol.org/dosage-guidelines/. May 26th 2019.
Paritakul, P., Phupong, V. 2010. Comparative study between oral and sublingual 600 μg misoprostol for the treatment of incomplete abortion. The Journal of Obstetrics and Gynaecology Research, 36(5): 978-983.
Diop, A., Raghavan, S., Rakotovao, J.P., Comendant, R., Blumenthal, P.D., Winikoff B. 2009. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception. 79:456-462.
Nguyen, T.N., Blum, J., Durocher, J., Quan, T.T.V., Winikoff, B. 2005. A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion. Contraception, 72(6):438-442.
Weeks, A., Alia, G., Blum, J., Winikoff, B., Ekwaru, P., Durocher, J., Mirembe, F. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstetrics & Gynecology, 106(3): 540-547.
Shwekerela, B., Kalumuna, R., Kipingili, R., Mashaka, N., Westheimer, E., Clark, W., Winikoff, B. 2007. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG: An International Journal of Obstetrics & Gynaecology, 114(11):1363-1367.
Dao, B., Blum, J., Thieba, B., Raghavan, S., Ouedraego, M., Lankoande, J., Winikoff, B. 2007. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG: An International Journal of Obstetrics & Gynaecology, 114: 1368-1375.
Bique, C., Usta, M., Debora, B., Chong, E., Westheimer, E., Winikoff, B. 2007. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. International Journal of Gynaecology & Obstetrics, 98:222-226.
Xiaobin, H., Miao, M., Yana, B., Ning, C., Xiaowei, R. 2018. Reproductive factors and risk of spontaneous abortion in the Jinchang Cohort. International Journal of Environmental Research and Public Health, 15:2444-2452.
Putri, R.W.Y. 2018. Hubungan usia, jumlah kehamilan, dan riwayat abortus spontan pada ibu hamil dengan kejadian abortus spontan di Rumah Sakit Umum Aghisna Medika Kabupaten Cilacap. Skripsi. Fakultas Kedokteran, Universitas Muhammadiyah Surakarta.
Zheng, D., Chunyan, L., Taiwen, W., Kun, T. 2017. Factors associated with spontaneous abortion: a cross-sectional study of Chinese populations. Reproductive Health, 14:33-41.
Pitriani. 2013. Faktor-faktor yang berhubungan dengan abortus inkomplit di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau. Jurnal Kesehatan Komunitas, 2(2):83-87.
Zikopoulos, K.A., Papanikolaou, E.G., Kalantaridou, S.N., Tsanadis, G.D., Plachouras, N.I., Dalkalistis, N.A., Paraskevaidis, E.A. 2002. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Human Reproduction, 17(12): 3079-3083.
Montesinos, R., Durocher, J., Leon, W., Arellano, M., Pena, M., Pinto, E., Winikoff, B. 2011. Oral misoprostol for the management of incomplete abortion in Ecuador. International Journal of Gynecology & Obstetrics, 115(2): 135-139.
Coyaji, K., Krishna, U., Ambardekar, S., Bracken, H., Raote, V., Mandlekar, A., Winikoff, B. 2007. Are two doses of misoprostol after mifepristone for early abortion better than one. BJOG: An International Journal of Obstetrics & Gynaecology, 114: 271-278.
Lumbiganon, P., Hofmeyr, J., Gulmezoglu, A.M., Pinol, A., Villar, J. 1999. Misoprostol dose-related shivering and pyrexia in the third stage of labour. British Journal of Obstetrics and Gynaecology, 106:304-308.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
